GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Scandinavian ChemoTech AB (OSTO:CMOTEC B) » Definitions » Debt-to-Asset

Scandinavian ChemoTech AB (OSTO:CMOTEC B) Debt-to-Asset : 0.00 (As of Mar. 2025)


View and export this data going back to 2016. Start your Free Trial

What is Scandinavian ChemoTech AB Debt-to-Asset?

Scandinavian ChemoTech AB's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Mar. 2025 was kr0.00 Mil. Scandinavian ChemoTech AB's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Mar. 2025 was kr0.00 Mil. Scandinavian ChemoTech AB's Long-Term Debt & Capital Lease ObligationTotal Assets for the quarter that ended in Mar. 2025 was kr13.07 Mil. Scandinavian ChemoTech AB's debt to asset for the quarter that ended in Mar. 2025 was 0.00.


Scandinavian ChemoTech AB Debt-to-Asset Historical Data

The historical data trend for Scandinavian ChemoTech AB's Debt-to-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Scandinavian ChemoTech AB Debt-to-Asset Chart

Scandinavian ChemoTech AB Annual Data
Trend Jun15 Jun16 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Debt-to-Asset
Get a 7-Day Free Trial Premium Member Only 0.17 - - - -

Scandinavian ChemoTech AB Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Debt-to-Asset Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Scandinavian ChemoTech AB's Debt-to-Asset

For the Biotechnology subindustry, Scandinavian ChemoTech AB's Debt-to-Asset, along with its competitors' market caps and Debt-to-Asset data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Scandinavian ChemoTech AB's Debt-to-Asset Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Scandinavian ChemoTech AB's Debt-to-Asset distribution charts can be found below:

* The bar in red indicates where Scandinavian ChemoTech AB's Debt-to-Asset falls into.


;
;

Scandinavian ChemoTech AB Debt-to-Asset Calculation

Debt to Asset measures the financial leverage a company has.

Scandinavian ChemoTech AB's Debt-to-Asset for the fiscal year that ended in Dec. 2024 is calculated as

Scandinavian ChemoTech AB's Debt-to-Asset for the quarter that ended in Mar. 2025 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Scandinavian ChemoTech AB  (OSTO:CMOTEC B) Debt-to-Asset Explanation

In the calculation of Debt-to-Asset, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Assets.


Scandinavian ChemoTech AB Debt-to-Asset Related Terms

Thank you for viewing the detailed overview of Scandinavian ChemoTech AB's Debt-to-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.


Scandinavian ChemoTech AB Business Description

Traded in Other Exchanges
N/A
Address
Scheelevagen 1, Medicon Village, Lund, SWE, 223 63
Scandinavian ChemoTech AB is a Sweden based clinical development company. It is engaged in research on pain management and therapy for prostate cancer.

Scandinavian ChemoTech AB Headlines

No Headlines